Investors Chronicle

Companies editor Ian Smith and the team discuss the week's takeover news, Imagination Technologies' Apple contract loss and RPC's bears.  See acast.com/privacy for privacy and opt-out information.

The subprime lender is delivering on the buy-and-build strategy it set out at admission to the main market two years ago. So why has its share price struggled? Its founder and chief executive, John van Kuffeler, discusses the group's growth, investment case and changing regulatory environment with the IC's companies editor Ian Smith.  See acast.com/privacy for privacy and opt-out information.

In this week's Personal Finance Show the team puts momentum investing under the microscope. Is it a good idea to buy winning stocks or is it a risky investment strategy? Deputy personal finance editor Kate Beioley talks to Rob Burgeman, investment manager at Brewin Dolphin and personal finance writer Emma Agyemang to weigh up the risks and rewards. The team also takes a look at two new high-income funds from Kames Capital and Miton and the investment trusts 'dividend heroes' that have increased their payouts for between 10 and 20 years.  See acast.com/privacy for privacy and opt-out information.

Editor John Hughman and guests discuss Brexit, corporate fines, ageing & more  See acast.com/privacy for privacy and opt-out information.

With money rotating out of bonds and into equity markets, value investing is back in vogue. But what constitutes value? How can investors spot it? And what are the common pitfalls? In this special podcast, tips editor Algy Hall and deputy companies editor Mark Robinson walk through the key measures and metrics beloved of value investors, with a little help from two of the UK's top fund managers. Produced by Graeme Davies, Dominic Toms and Alex Newman.  See acast.com/privacy for privacy and opt-out information.

Aviva faces regulatory changes, such as the 2015 pensions freedom reforms. It has been on the M&A trail, through its takeover of rival Friends Life. And now, it has set its sights on disrupting the Asian life market. It's also been a decent long-term investment since a strategic shift in 2012. Cash generation is up, debt is down, and non-core businesses are gone. Financial services writer Emma Powell spoke to Aviva's head of UK insurance Andy Briggs about the how investors can value life assurance in a diversifying business. Produced by Dominic Toms.  See acast.com/privacy for privacy and opt-out information.

In this week's show the team consider how to pick a good fund manager, and highlight some examples. They also look at the risks and rewards of the Lifetime Isa, which is set to launch next month. They are joined by Darius McDermott, managing director at Chelsea Financial Services.  See acast.com/privacy for privacy and opt-out information.

Editor John Hughman and guests discuss Sky/Fox, drug developments and cognitive biases in our weekly podcast  See acast.com/privacy for privacy and opt-out information.

Summit Therapeutics is a small-cap biotech company with two drugs in clinical trials at either end of the new drugs space: a low risk, lower reward antibiotic and a high risk, higher reward Duchenne Muscular Dystrophy cure. Does this make it an ideal biotech investment? Megan Boxall investigates.  See acast.com/privacy for privacy and opt-out information.

In this week's show James Baxter, partner at Tideway Wealth, joins the team to look at which investment trusts have proved to be the most reliable dividend payers over the years. They also consider some changes to the requirements for UK Equity Income sector funds and highlight a tax allowance that is soon to disappear.  See acast.com/privacy for privacy and opt-out information.

IC editor John Hughman, news editor Emma Powell and companies editor Ian Smith discuss the week's big news, including the surge in M&A and continuing regulatory ructions in the telecoms and media industry.  See acast.com/privacy for privacy and opt-out information.

BT's (BT.A) chief executive, Gavin Patterson, is not the only FTSE 100 boss to have announced a profit warning since the start of 2017. Several high profile companies have been forced to restate guidance since the start of the year. So is this a side effect of the current macroeconomic instability or do investors need to be wary of company structural issues which pre-date Brexit-related turmoil? And do these profit warnings present buying opportunities or should investors jump ship from companies in turmoil? In this podcast Alan Hudson, partner at EY, and the IC's companies editor, Ian Smith, join Megan Boxall to discuss why so many companies have had such a rough start to 2017. Introduction audio is the copyright of Reuters and BT.  See acast.com/privacy for privacy and opt-out information.

The importance of nutrition in sporting success has created a big market for elite sports supplements. But is the market for amateur athletes big enough to support growth at Aim-listed group Science in Sport (SIS)? Megan Boxall talks to the group's chief executive, Stephen Moon.  See acast.com/privacy for privacy and opt-out information.

In this week's show the personal team and Chris Dillow, Investors Chronicle's economist, look at how some tax changes announced in Wednesday's budget will affect savers and investors. They also look at how to pick a good equity income fund and the merits of holding shares in your employer.  See acast.com/privacy for privacy and opt-out information.

IC editor John Hughman talks to Mark Robinson about why investors should position their portfolios for a surge in defence spending, plus the latest news and results with companies editor Ian Smith.  See acast.com/privacy for privacy and opt-out information.

The UK and US stock markets have hit record highs in 2017 but are investors kidding themselves that valuations are sustainable? Professor Robert Shiller, Nobel Prize winner and current president of the American Economic Association, is advocating more research into how investors pick the narratives that take hold and drive prices higher. In his interview with the IC's James Norrington, he discusses how investors’ psychological traits take hold, why Mark Carney’s reaction to the Brexit vote may have been right and ask: is it wishful thinking or inspiration that drives investment in shares?  See acast.com/privacy for privacy and opt-out information.

In this week's Isa special podcast Sarah Lord, board director of the Personal Finance Society, explains some of the ways you can use an Isa for your saving and investing goals. The IC personal finance team also explain what the different types of Isa are, and how you can buy one in the most cost effective way.  See acast.com/privacy for privacy and opt-out information.

Editor John Hughman and guests discuss a wide range of topics from insurance to pasties to Georgian rugby as well as all the main news and features in this week's magazine.  See acast.com/privacy for privacy and opt-out information.

Nowadays, Stobart Group is about a lot more than haulage trucks. Apart from a residual, non-controlling stake in Eddie Stobart Logistics, the Carlisle-headquartered company’s operations span everything from biomass supply, to managing airports, rail engineering and aircraft leasing. How do investors pick apart these diverse sectors? And how will the company go about fulfilling its big dividend commitments? And what’s next for its CEO? IC writer Alex Newman puts these questions and more to chief executive officer Andrew Tinkler and executive director Richard Butler in the latest episode of Boardroom Talk. Produced by Dominic Toms  See acast.com/privacy for privacy and opt-out information.

In this week's personal finance podcast the team look at what is really generating growth in tech stocks with special guest Dennis Hall, chief executive officer of Yellowtail Financial Planning. They also consider the merits of investing in the Alternative Investment Market (Aim) and how to save for retirement costs.  See acast.com/privacy for privacy and opt-out information.